Wednesday, May 4, 2016
(10 AM Pacific, 11 AM Mountain, 12 Noon Central, 1 PM Eastern):
James L. Beebe, PhD, D(ABMM)
Microbiology Special Event #SpMV-2: The Zika Virus: Implications for Clinical and Public Health Laboratories (Webinar & Recording downloaded from cloud) $115.00 BUY NOW
Microbiology Special Event #SpMV-2: The Zika Virus: Implications for Clinical and Public Health Laboratories (Webinar & Recording on CD) $133.00 BUY NOW
Don’t Miss this Important and Timely Webinar
February 1, 2016 – World Health Organization declared a Public Health Emergency of
International Concern (PHEIC) due to clusters of microcephaly
and other neurological disorders in areas affected by the Zika virus.
February 8, 2016 – CDC elevates its response efforts to a Level 1 activation, the
highest response level at the CDC.
At the completion of this Session, the participant will be able to:
- List the reasons for the emergence of this new virus
- Describe how patients infected with new viruses will present in the medical community and what laboratory diagnostic assets/methods (e.g.RT-PCR, ELISA) can be applied.
- Describe appropriate safety, specimen collection, shipping, and reporting guidelines.
- Define what factors will allow certain viruses to become established in the United
States and continue to cause illness.